Navignostics

Navignostics provides spatial single-cell proteomics services by combining multiplex protein imaging with advanced data analytics to analyze tumor samples. The company supports clinicians in identifying optimal personalized cancer therapies and assists pharmaceutical researchers in biomarker identification and clinical trial patient selection. Their technology utilizes Imaging Mass Cytometry to provide biological insights into cellular composition and direct drug targets.